Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofGemcitabine for Injectionfrom Surat, Gujarat, India. Gemcitabine For Injection used as a first-line treatment alone for pancreatic cancer, and in combination with cisplatin for advanced or metastatic bladder cancer and advanced or metastatic non-small cell lung cancer.
Tags: Gemcitabine for Injection manufacturer, Gemcitabine forInjection exporter, Gemcitabine for Injection supplier, and Gemcitabine forInjection, whogmp approved Gemcitabine for Injection manufacturer and supplier,Gemcitabine for Injection distributor, Gemcitabine for Injection shipper, Gemcitabine ForInjection200 mgGemcitabine for Injection 200 mgsupplier,Gemcitabine for Injection 200 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceGemcitabine forInjection export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Targeted Cancer Therapy for AdultsGemcitabine for Injection offers a reliable treatment option for adults with specific cancers, namely pancreatic, ovarian, breast, and non-small cell lung cancer. It is administered under the direction of a healthcare professional, ensuring tailored care for eligible patients. With established clinical benefits and compliance with international standards, patients and providers can trust its efficacy and quality.
Safe Preparation and Handling ProceduresAs a cytotoxic medication, Gemcitabine requires specialized handling measures to safeguard both healthcare providers and the environment. The medication is reconstituted with 0.9% Sodium Chloride Injection, USP, ensuring optimal solubility for intravenous infusion. Comprehensive packaging, including a clear package insert, supports precise and safe administration.
Flexible Dosage Strengths to Meet Clinical NeedsAvailable in 200 mg and 1 g strengths per vial, Gemcitabine for Injection allows for customized dosing as required by individual treatment regimens. This flexibility supports oncologists and pharmacists in delivering treatments that are aligned with specific patient needs, maximizing therapeutic benefit while maintaining safety standards.
FAQ's of Gemcitabine for Injection:
Q: How should Gemcitabine for Injection be reconstituted for administration?
A: Gemcitabine for Injection must be reconstituted using 0.9% Sodium Chloride Injection, USP. Carefully follow the package insert instructions for accurate dilution to ensure safety and efficacy. Only trained healthcare professionals should perform this procedure under cytotoxic precautions.
Q: What types of cancers can Gemcitabine for Injection treat?
A: Gemcitabine for Injection is indicated for the treatment of pancreatic, ovarian, breast, and non-small cell lung cancer in adult patients. Its efficacy is supported for these specific cancer types under a healthcare provider's supervision.
Q: When should Gemcitabine for Injection be administered to patients?
A: This medication is administered according to the specific cancer treatment protocol prescribed by an oncologist. Patients typically receive Gemcitabine as part of scheduled intravenous infusions, tailored to their individual treatment plans.
Q: Where should Gemcitabine for Injection be stored before use?
A: The vials should be stored in a cool and dry place at the facility, ensuring protection from excessive heat and humidity. Always keep the medication in its original carton until it is ready for use, and check the package insert for any additional storage guidelines.
Q: What precautions should be taken during the handling and preparation of Gemcitabine for Injection?
A: Due to its cytotoxic nature, always handle Gemcitabine for Injection with specialized protective equipment, including gloves and a mask if necessary. Follow institutional protocols for cytotoxic drug handling and disposal to protect both staff and the environment.
Q: What are the benefits of using Gemcitabine for Injection for cancer treatment?
A: Gemcitabine for Injection offers targeted, effective therapy for various cancers, and its flexibility in dosing allows for individualized treatment plans. The medication is manufactured in compliance with USP/BP standards, ensuring quality and patient safety.
Q: Who can prescribe and administer Gemcitabine for Injection?
A: Only licensed medical professionals-typically oncologists or healthcare providers specializing in cancer treatment-can prescribe and oversee the administration of Gemcitabine for Injection. This ensures that the medication is used appropriately and safely for eligible adult patients.